Wolverine Trading’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $58.6M | Buy |
+183,300
| New | +$57M | 0.04% | 285 |
|
|
2025
Q2 | – | Sell |
-62,300
| Closed | -$26.9M | – | 4967 |
|
|
2025
Q1 | $26.9M | Sell |
62,300
-23,100
| -27% | -$9.27M | 0.03% | 325 |
|
|
2024
Q4 | $31.5M | Buy |
85,400
+31,500
| +58% | +$13.2M | 0.03% | 340 |
|
|
2024
Q3 | $28.2M | Buy |
53,900
+15,600
| +41% | +$8.33M | 0.03% | 331 |
|
|
2024
Q2 | $20.8M | Sell |
38,300
-21,600
| -36% | -$11.4M | 0.02% | 383 |
|
|
2024
Q1 | $31.1M | Buy |
59,900
+4,400
| +8% | +$2.19M | 0.03% | 298 |
|
|
2023
Q4 | $26.2M | Buy |
55,500
+4,900
| +10% | +$2.27M | 0.03% | 368 |
|
|
2023
Q3 | $22M | Buy |
50,600
+1,700
| +3% | +$771K | 0.02% | 347 |
|
|
2023
Q2 | $21.5M | Buy |
48,900
+25,600
| +110% | +$11.8M | 0.03% | 337 |
|
|
2023
Q1 | $10.7M | Sell |
23,300
-2,400
| -9% | -$1.14M | 0.02% | 517 |
|
|
2022
Q4 | $13.2M | Buy |
25,700
+7,900
| +44% | +$4.01M | 0.02% | 522 |
|
|
2022
Q3 | $8.13M | Buy |
17,800
+2,400
| +16% | +$1.15M | 0.01% | 642 |
|
|
2022
Q2 | $7.48M | Sell |
15,400
-17,100
| -53% | -$8.46M | 0.01% | 634 |
|
|
2022
Q1 | $16.3M | Buy |
+32,500
| New | +$14.9M | 0.02% | 502 |
|
|
2021
Q4 | – | Sell |
-44,100
| Closed | -$17.1M | – | 6126 |
|
|
2021
Q3 | $17.1M | Buy |
+44,100
| New | +$16.8M | 0.02% | 582 |
|
|
2021
Q2 | – | Sell |
-30,600
| Closed | -$11.1M | – | 6180 |
|
|
2021
Q1 | $11.1M | Sell |
30,600
-5,900
| -16% | -$1.9M | 0.02% | 636 |
|
|
2020
Q4 | $11.5M | Sell |
36,500
-9,000
| -20% | -$2.76M | 0.02% | 618 |
|
|
2020
Q3 | $11.8M | Buy |
45,500
+9,100
| +25% | +$2.45M | 0.03% | 467 |
|
|
2020
Q2 | $9.44M | Sell |
36,400
-20,300
| -36% | -$5.42M | 0.03% | 483 |
|
|
2020
Q1 | $13.1M | Sell |
56,700
-26,000
| -31% | -$7.09M | 0.04% | 341 |
|
|
2019
Q4 | $25.2M | Buy |
82,700
+5,100
| +7% | +$1.4M | 0.06% | 272 |
|
|
2019
Q3 | $18.4M | Sell |
77,600
-13,100
| -14% | -$3.59M | 0.05% | 302 |
|
|
2019
Q2 | $25.6M | Buy |
90,700
+26,300
| +41% | +$7.18M | 0.07% | 220 |
|
|
2019
Q1 | $18.5M | Buy |
64,400
+11,000
| +21% | +$3.18M | 0.05% | 282 |
|
|
2018
Q4 | $13.8M | Buy |
53,400
+1,000
| +2% | +$275K | 0.04% | 354 |
|
|
2018
Q3 | $14.4M | Sell |
52,400
-1,000
| -2% | -$260K | 0.03% | 405 |
|
|
2018
Q2 | $11.7M | Hold |
53,400
| – | – | 0.03% | 434 |
|
|
2018
Q1 | $11.7M | Buy |
+53,400
| New | +$12.5M | 0.03% | 434 |
|
|
2017
Q4 | – | Sell |
-75,500
| Closed | -$14.3M | – | 5049 |
|
|
2017
Q3 | $14.3M | Buy |
75,500
+27,400
| +57% | +$5.21M | 0.05% | 296 |
|
|
2017
Q2 | $9M | Sell |
48,100
-4,700
| -9% | -$844K | 0.04% | 406 |
|
|
2017
Q1 | $8.82M | Buy |
52,800
+17,400
| +49% | +$2.77M | 0.05% | 393 |
|
|
2016
Q4 | $5.09M | Sell |
35,400
-26,700
| -43% | -$3.58M | 0.03% | 723 |
|
|
2016
Q3 | $7.76M | Buy |
+62,100
| New | +$8.02M | 0.04% | 541 |
|
Other funds holding ELV
Wolverine Trading's ELV Position: Q2 2025 in Review
Wolverine Trading sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 8,997 shares — an estimated $3.89M sold.
Wolverine Trading first reported a position in ELV in Q3 2016 and held it in 21 quarters. The position peaked at $10.4M in Q2 2019. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.
- Wolverine Trading reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
- Wolverine Trading sold 8,997 Elevance Health shares in Q2 2025, an estimated $3.89M.
- Wolverine Trading first reported a position in Elevance Health in Q3 2016 and held it in 21 quarters.
- Wolverine Trading's Elevance Health position peaked at $10.4M in Q2 2019.
- 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.
Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.